Loading...
AbbVie Inc.
ABBV•NYSE
Healthcare
Drug Manufacturers - General
$190.28
$-0.55(-0.29%)
AbbVie Inc. (ABBV) Financial Performance & Income Statement Overview
Review AbbVie Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.71%
↑ 3.71%
Operating Income Growth
30.32%
↑ 30.32%
Net Income Growth
-12.03%
↓ 12.03%
Operating Cash Flow Growth
-17.66%
↓ 17.66%
Operating Margin
28.31%
↑ 28.31%
Gross Margin
77.46%
↑ 77.46%
Net Profit Margin
7.31%
↑ 7.31%
ROE
95.59%
↑ 95.59%
ROIC
16.28%
↑ 16.28%
AbbVie Inc. (ABBV) Income Statement & Financial Overview
Review AbbVie Inc.'s (ABBV) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $13.34B | $15.10B | $14.46B | $14.46B |
Cost of Revenue | $4.002B | $4.40B | $4.21B | $4.20B |
Gross Profit | $9.34B | $10.71B | $10.25B | $10.26B |
Gross Profit Ratio | $0.84 | $0.71 | $0.71 | $0.85 |
R&D Expenses | $2.07B | $6.77B | $2.13B | $1.95B |
SG&A Expenses | $3.29B | $3.85B | $4.21B | $3.38B |
Operating Expenses | $5.61B | $12.20B | $6.42B | $6.26B |
Total Costs & Expenses | $9.61B | $16.59B | $10.63B | $10.46B |
Interest Income | $73.00M | $92.00M | $0.00 | $220.00M |
Interest Expense | $700.00M | $702.00M | $591.00M | $726.00M |
Depreciation & Amortization | $2.04B | $2.10B | $2.08B | $2.13B |
EBITDA | $4.40B | $535.00M | $4.88B | $5.003B |
EBITDA Ratio | $0.28 | $0.04 | $0.34 | $0.49 |
Operating Income | $3.73B | -$1.49B | $3.83B | $4.00B |
Operating Income Ratio | $0.28 | $0.31 | $0.26 | $0.28 |
Other Income/Expenses (Net) | -$2.07B | -$779.00M | -$1.75B | -$1.85B |
Income Before Tax | $1.66B | -$2.27B | $2.08B | $2.15B |
Income Before Tax Ratio | $0.12 | -$0.15 | $0.14 | $0.15 |
Income Tax Expense | $372.00M | -$2.25B | $520.00M | $773.00M |
Net Income | $1.29B | -$22.00M | $1.56B | $1.37B |
Net Income Ratio | $0.10 | -$0.001 | $0.11 | $0.09 |
EPS | $0.72 | -$0.02 | $0.88 | $0.78 |
Diluted EPS | $0.72 | -$0.02 | $0.88 | $0.78 |
Weighted Avg Shares Outstanding | $1.77B | $1.77B | $1.77B | $1.77B |
Weighted Avg Shares Outstanding (Diluted) | $1.77B | $1.77B | $1.77B | $1.77B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan